3 advances in septic shock diagnosis and treatment

Septic shock affects more than 230,000 U.S. patients each year, but JAMA has published new advances in diagnosing and treating this clinical emergency in hopes of reducing that number.

Advertisement

Here are three updates in septic shock care.

1. To recognize complicating factors such as hypovolemia or cardiogenic shock in patient, the JAMA article authors recommend focused ultrasonography. Invasive hemodynamic monitoring is recommended only for select patients.

2. In septic shock, three randomized clinical trials have demonstrated that protocolized care offers little advantage compared to management without a protocol.

3. Hydroxyethyl starch is no longer recommended for septic shock patients, and debate continues about the role of various crystalloid solutions and albumin.

To read the full report, click here.

 

 

More articles on sepsis and septic shock:
New algorithm can help detect sepsis earlier
6 strategies to improve early sepsis recognition
Wolters Kluwer Health piloting app to fight sepsis

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.